- Solar park can generate up to 40% of the energy needs at its 5
hectare facility in Doima, Colombia
- Project demonstrates Khiron's commitment to sustainability by
reducing its carbon footprint by approximately 7 tons of CO2 a
year, while decreasing operational energy costs
TORONTO, June 24, 2020 /CNW/ - Khiron Life Sciences
Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF),
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America and Europe, announces the completed installation
of a state-of-the-art 2,600 panel solar park that will generate
electricity to power the Company's production facility in Doima,
Colombia.
Developed with ReFeel, a leading Italian renewable Company with
more than 80 MW installed in Europe and Latin
America, Khiron's solar park is expected to generate up to
700 kWh through a photovoltaic (PV) system that comprises
2,618 installed solar panels. With the construction of the PV
system, Khiron can self-generate up to 40% of the energy it needs
for day-to-day facility operations and is expected to reduce CO2
emissions by 570 tons a year.
"Installation of the solar park at our Doima production facility
brings Khiron exponential efficiencies, allowing us to
significantly reduce operational energy costs and benefit from tax
reductions, as we actively commit to deploying sustainability
initiatives across our operations," comments Khiron CEO and
Director Alvaro Torres. "We're proud
to take actions aimed at sharply reducing greenhouse gas emissions
and making this contribution to help counter the global
environmental challenge."
The solar park project delivered direct employment to a team of
20 personnel in the local Doima community and provided access to
globally recognized solar energy technical training in PV
systems and renewable energy installations, enhancing the teams
future participation in projects of the same type, at a regional
and national level. "We are continuing to support the Doima
community, improving resource and waste management in the area as
part of our company-wide sustainability program," continues, Mr.
Torres.
View the Khiron facilities image portfolio at:
https://investors.khiron.ca/media-room/facilities
About Khiron Life Sciences Corp.
Khiron is a vertically integrated medical and CPG cannabis
company with core operations in Latin
America, and operational activity in Europe and North America. Khiron is
the leading cannabis company in Colombia and the first company licensed
in Colombia for the cultivation, production, domestic
distribution, and international export of both low and high THC
medical cannabis products. The Company has presence in Mexico, Peru,
Uruguay, Brazil, UK and Germany, where it is positioned to begin sales
of medical cannabis.
Leveraging its first-mover advantage, and patient oriented
approach, Khiron combines global scientific expertise, product
innovation, agricultural infrastructure, wholly-owned medical
clinics, and online doctor education programs to drive prescription
and brand loyalty to address priority medical conditions. Its
Wellbeing unit launched the first branded CBD skincare brand in
Colombia, with Kuida now marketed
in multiple jurisdictions in Latin
America, the US and UK. The Company is led by Co-founder and
Chief Executive Officer, Alvaro
Torres, together with an experienced and diverse
executive team and Board of Directors
Visit Khiron online at www.khiron.ca,
investors.khiron.ca and on Instagram @khironlife
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment analyses,
expectations or statements made by third-parties in respect of
Khiron, its securities, or financial or operating results (as
applicable). Although Khiron believes that the expectations
reflected in forward-looking statements in this press release are
reasonable, such forward-looking statement has been based on
expectations, factors and assumptions concerning future events
which may prove to be inaccurate and are subject to numerous risks
and uncertainties, certain of which are beyond Khiron's control,
including the risk factors discussed in Khiron's Annual Information
Form which is available on Khiron's SEDAR profile at www.sedar.com.
The forward-looking information contained in this press release is
expressly qualified by this cautionary statement and are made as of
the date hereof. Khiron disclaims any intention and has no
obligation or responsibility, except as required by law, to update
or revise any forward-looking information, whether as a result of
new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-goes-green-completing-1-megawatt-solar-energy-park-in-colombia-301082656.html
SOURCE Khiron Life Sciences Corp.